Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $30.4700 (1.36%) ($30.4700 - $30.4700) on Thu. Apr. 15, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.85% (three month average) | RSI | 52 | Latest Price | $30.4700(1.36%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -0.5% a day on average for past five trading days. | Weekly Trend | IOVA declines -0.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(46%) XBI(42%) ARKG(40%) IWO(40%) IWC(38%) | Factors Impacting IOVA price | IOVA will decline at least -1.925% in a week (0% probabilities). VIXM(-23%) UUP(-16%) VXX(-11%) TBT(-5%) UNG(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.925% (StdDev 3.85%) | Hourly BBV | 0.2 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $30.74 | 5 Day Moving Average | $30.07(1.33%) | 10 Day Moving Average | $30.84(-1.2%) | 20 Day Moving Average | $30.74(-0.88%) | To recent high | -42.1% | To recent low | 6.3% | Market Cap | $4.462b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |